AI-Powered Biotech Due Diligence: Structure Therapeutics and the $100B GLP-1 Opportunity
K-Dense Web delivers a 7-step due diligence on Structure Therapeutics' GSBR-1290, an oral GLP-1 agonist targeting a $6.5B peak revenue obesity opportunity.
Blog
Insights & Updates
Explore tutorials, product updates, and insights on AI-powered research automation from the K-Dense team.
Filter by:AllAIARPA-HBenchmarksBiologyBiomarker DiscoveryBiotechCase StudyChemistryClinical TrialsCommunityCompetitive IntelligenceData ScienceDrug DevelopmentDrug DiscoveryDue DiligenceEnterpriseFDAFinanceGBMGPUHealth PolicyHealthcareImmunotherapyInvestment AnalysisK-Dense BYOKK-Dense WebMachine LearningMass SpectrometryMedical DevicesMetabolomicsMultimodalNVIDIANeoantigenOSINTOncologyOpen SourceOpinionPhDPharmaProductProteomicsPublic HealthPublic PolicyReproducibilityResearchResearch FundingResearch PlanningRoboticsScienceScientific Agent SkillsScientific IntegritySecuritySkillsTranslational ResearchTutorialUAPUse Case
Showing 2 posts tagged "Biotech".
Pharma Competitive Intelligence in One Session: CT-388 and the GLP-1/GIP Obesity Landscape
K-Dense Web queried 4 databases and ran 7 Python scripts to produce a 44-page competitive intelligence report on CT-388, Roche's GLP-1/GIP obesity agonist.